Moxetumomab [CAS 1622075-65-3]
Partner: MedChemexpress LLC
CAS No: | 1622075-65-3 |
Applications: | COVID-19-immunoregulation |
MW: | N/A |
Formula: | N/A |
SMILES: | [Moxetumomab] |
Purity: | 95.00 |
Description: | Moxetumomab, a recombinant CD22-targeting immunotoxin, can be used for the research of hairy cell leukemia (HCL)[1][2]. |
Shipping Conditions: | Ship on dry ice |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice